SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

JP Morgan Maintains Overweight on Acceleron Pharma, Raises Price Target to $118

JP Morgan maintains Acceleron Pharma (NASDAQ:XLRN) with a Overweight and raises the price target from $108 to $118.

Benzinga · 05/12/2020 14:33

JP Morgan maintains Acceleron Pharma (NASDAQ:XLRN) with a Overweight and raises the price target from $108 to $118.